Clinical and genetic aspects of progressive supranuclear palsy

Journal of Geriatric Psychiatry and Neurology

Volumn 11, Issue 2, 1998, Pages 107-114

  Litvan, Irene ^a   Hutton, Michael ^b  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ADULT; AGED; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; GENE MUTATION; HUMAN; NEUROPATHOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RECESSIVE INHERITANCE; REVIEW;

EID: 0032405638     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/089198879801100208     Document Type: Review

References (92)

1. Litvan I, Mangone ÇA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996; 60:615-620.
2. Mäher ER, Lees AJ. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986; 36:1005-1008.
3. Tanigawa A, Komiyama A, Hasegawa O. Truncal muscle tonus in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1998; 64:190-196.
4. Dubas F, Gray F, Escourolle R. Steele-Richardson-Olszewski disease without ophthalmoplegia. 6 clinico-anatomic cases. Rev Neurol (Paris) 1983; 139:407-416.
5. Daniel SE, De Bruin VMS, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995; 118:759-770.
6. Vidailhet M, Rivaud S, Gouider-Khouja N, et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994; 35:420-426.
7. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (SteeleRichardson-Olszewski syndrome). Report of the NINDS-SPSP International Workshop. Neurology 1996; 47:1-9.
8. De Bruin VM, Lees AJ, Daniel SE. Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report. Mov Disord 1992; 7:355-358.
9. Amarenco P, Roullet E, Hannoun L, Marteau R. Progressive supranuclear palsy as the sole manifestation of systemic Whipple's disease treated with pefloxacine [letter]. J Neurol Neurosurg Psychiatry 1991; 54:1121-1122.
10. De Bruin VM, Lees AJ. Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases. Mov Disord 1994; 9:381-389.
11. Kluin KJ, Foster NL, Berent S, Gilman S. Perceptual analysis of speech disorders in progressive supranuclear palsy. Neurology 1993; 43:563-566.
12. Litvan I, Sastry N, Sonies BC. Characterizing swallowing abnormalities in progressive supranuclear palsy. Neurology 1997; 48:1654-1662.
13. Grafman J, Litvan I, Gomez C, Chase TN. Frontal lobe function in progressive supranuclear palsy. Arch Neurol 1990; 47:553-558.
14. Pillon B, Dubois B, Lhermitte F, Agid Y. Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology 1986; 36:1179-1185.
15. Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991; 41:634-643.
16. Pillon B, Blin J, Vidailhet M, et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995; 45:1477-1483.
17. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatrie aspects of progressive supranuclear palsy. Neurology 1997; 47:1184-1189.
18. Gambier J, Masson M, Viader F, et al. Frontal syndrome of progressive supranuclear palsy. Rev Neurol (Paris) 1985; 141:528-536.
19. Mäher ER, Smith EM, Lees AJ. Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). J Neurol Neurosurg Psychiatry 1985; 48: 1234-1239.
20. Pillon B, Gouider-Khouja N, Deweer B, et al. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1995; 58:174-179.
21. Robbins TW, James M, Owen AM, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 1994; 57:79-88.
22. Santacruz P, Util B, Litvan I, Grafman J. Progressive supranuclear palsy: a survey of disease course. Neurology 1998; 50:1637-1647.
23. Nuwer M. Progressive supranuclear palsy despite normal eye movements. Arch Neurol 1981; 38:784.
24. Dubas F, Gray F, Escourolle R. Maladie de Steele-RichardsonOlszewski sans ophtalmoplegie. Rev Neurol 1983; 139:407-416.
25. Masliah E, Hansen L, Quijada S, et al. Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy? Ann Neurol 1991; 29:389-396.
26. Matsuo H, Takashima H, Kishikawa M, et al. Pure akinesia: an atypical manifestation of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1991; 54:397-400.
27. Mizusawa H, Mochizuki A, Ohkoshi N, et al. Progressive supranuclear palsy presenting with pure akinesia. Adv Neurol 1993; 60:618-621.
28. Riley DE, Fogt N, Leigh RJ. The syndrome of'pure akinesia' and its relationship to progressive supranuclear palsy. Neurology 1994; 44:1025-1029.
29. Bergeron C, Pollanen MS, Weyer L, Lang AE. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. J Neuropathol Exp Neurol 1997; 56:726-734.
30. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17:427-442.
31. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (SteeleRichardson-Olszewski syndrome). Neurology 1996; 46:922-930.
32. Riley DE, Lang AE, Lewis A, et al. Cortical-basal ganglionic degeneration. Neurology 1990; 40:1203-1212.
33. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathological study. Neurology 1997; 48:119-125.
34. Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 corticobasal degeneration patients confirmed at autopsy. J Neurol Neurosurg Psychiatry 1998; 64:184-189.
35. Sakakibara R, Hattori T, Tojo M, et al. Micturitional disturbance in progressive supranuclear palsy. J Auton Nerv Syst 1993; 45:101-106.
36. Wakatsuki A, Tsujihata M, Miyake O, et al. Vesicourethral function study and application of urinary alarm in progressive supranuclear palsy. Hinyokika Kiyo 1993; 39:891-897.
37. Quinn N. Multiple system atrophy-the nature of the beast. J Neurol Neurosurg Psychiatry 1989; Suppl:78-89.
38. Wenning GK, Tison F, Ben-Shlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997; 12:133-147.
39. Litvan I, Campbell G, Mangone ÇA, et al. Which clinical features differentiate progressive supranuclear palsy (SteeleRichardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 1997; 120:65-74.
40. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol 1996; 40:139-148.
41. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol 1964; 10:333-359.
42. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syn-drome (progressive supranuclear palsy). Neurology 1994; 44:2015-2019.
43. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996; 55:97-105.
44. Conrad C, Andreadis A, Trojanowski JQ, et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 1997; 41:277-281.
45. Nishimura M, Namba Y, Ikeda K, Oda M. Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy. Neurosci Lett 1992; 143:35-38.
46. Ikeda K, Akiyama H, Kondo H, et al. Thorn-shaped astrocytes: possibly secondarily induced tau-positive glial fibrillary tangles. Ada Neuropathol 1995; 90:620-625.
47. Delacourte A, Sergeant N, Wattez A, et al. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Ann Neuroi 1998; 43:193-204.
48. Spillantini MG, Goedert M, Crowther RA, et al. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. ProcNatlAcad Sci U S A 1997; 94:4113-4118.
49. Buee-Scherrer V, Leveugle B, Perl DP, et al. Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other degenerative disorders. Ann Neuroi 1997;42:356-359.
50. Kertesz A. Frontotemporal dementia, Pick disease, and corticobasal degeneration. One entity or 3? Arch Neurol 1997; 54:1427-1429.
51. Vermersch P, Robitaille Y, Bernier L, et al. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol (Berl) 1994; 87:572-577.
52. Vermersch P, Bordet R, Ledoze F, et al. Demonstration of a specific profile of pathological Tau proteins in frontotemporal dementia cases. C R Acad Sci III 1995; 318:43945.
53. Feany MB, Ksiezak-Reding H, Liu WK, et al. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol (Berl) 1995; 90:37-43.
54. Komori T, Arai N, Oda M, et al. Morphologic difference of neuropil threads in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy: a morphometric study. Neurosci Lett 1997; 233:89-92.
55. Stacy M, Jankovic J. Differential diagnosis of Parkinson's disease and the parkinsonism plus syndromes. Neurol Clin 1992; 10:341-359.
56. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmstead County, Minnesota, 1976 to 1990. Neurology 1997; 49:1284-1288.
57. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am JEpidemiol 1995; 142:820-827.
58. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988; 38:1031-1034.
59. Parkinson Study Group. Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Ann Neurol 1998; 43: 318-325.
60. Hughes A J, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55:181-184.
61. Lees AJ. The Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Mou Disord 1987; 2:272-287.
62. Ohara S, Kondo K, Morita H, et al. Progressive supranuclear palsy-like syndrome in two siblings of a consanguineous marriage. Neurology 1992; 42:1009-1014.
63. Brown J, Lantos P, Stratton M, et al. Familial progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1993; 56:473-476.
64. Gazely S, Maguire J. Familial progressive supranuclear palsy [abstract]. Brain Pathol 1994; 4:534.
65. Tetrud JW, Golbe LI, Forno LS, Farmer PM. Autopsy-proven progressive supranuclear palsy in two siblings. Neurology 1996; 46:931-934.
66. de Yebenes JG, Sarasa JL, Daniel SE, Lees AJ. Familial progressive supranuclear palsy: description of a pedigree and review of the literature. Brain 1995; 118:1095-1103.
67. Higgins JJ, Litvan I, Pho LT, et al. Progressive supranuclear palsy is a recessive disorder in linkage disequilibrium with the tau and not the alpha-synuclein gene. Neurology 1998; 50:270-273.
68. Lazzarini AM, Golbe LI, Dickson DW, et al. Tau intronic polymorphism in Parkinson's disease and progressive supranuclear palsy [abstract]. Neurology 1997; 48(Suppl):A427.
69. Jellinger KA, Bancher C. Neuropathology. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:44-88.
70. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998; 43:815-825.
71. Spillantini MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. ProcNatlAcad Sci USA 1998; 95:7737-7741.
72. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393:702-705.
73. Tabaton M, Rollen M, Masturzo P, et al. Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy. Neurology 1995; 45:1764-1765.
74. Arai H, Higuchi S, Muramatsu T, et al. Lack of association of apolipoprotein E epsilon 4 allele with progressive supranuclear palsy [letter]. Neurodegeneration 1996; 5:194-195.
75. Anouti A, Schmidt K, Lyons KE, et al. Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy. Neurology 1996; 46:1156-1157.
76. Sawa A, Amano N, Yamada N, et al. Apolipoprotein E in progressive supranuclear palsy in Japan. Mol Psychiatry 1997; 2:341-342.
77. Litvan I, Saunders AM. Apolipoprotein E epsilon 4 allele does not affect the onset or symptom severity in progressive supranuclear palsy [letter]. Arch Neurol 1998; 55:752-754.
78. Saunders AM, Hulette O, Welsh-Bohmer KA, et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996; 348:90-93.
79. Ikeda K, Akiyama H, Sahara N, et al. Senile dementia with abundant neurofibrillary tangles without accompanying senile plaques: a subset of senile dementia with high incidence of the APOE epsilon 2 allele. In: Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewski HM, eds. Alzheimer's disease: biology, diagnosis and therapeutics. New York: John Wiley & Sons, 1997:257-265.
80. Davis PH, Golbe LI, Duvoisin RC, Schoenberg BS. Risk factors for progressive supranuclear palsy. Neurology 1988; 38:1546-1552.
81. Golbe LI, Rubin RS, Cody RP, et al. Follow-up study of risk factors in progressive supranuclear palsy. Neurology 1996; 47:148-154.
82. Yamada T, McGeer P, McGeer E. Appearance of paired nucleated, tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett 1992; 135:99-102.
83. Yamada T, Gaine DB, Akiyama H, et al. Further observations on tau-positive glia in the brains with progressive supranuclear palsy. Ada Neuropathol (Berl) 1993; 85:308-315.
84. Ikeda K Glial degeneration. In: Dani SU, Hori A, Walter GF, eds. Principles of neural aging. Amsterdan: Elsevier, 1997: 343-357.
85. Ikeda K, Akiyama H, Arai T, Nishimura T. Glial tau pathology in neurodegenerative diseases: their nature and comparison with neuronal tangles. Neurobiol Aging 1998; 19(Suppl 1):S85-S91.
86. Agid Y. Conclusions. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:270-273.
87. Litvan I, Chase TN. Traditional and experimental therapeutic approaches. In: Litvan I, Agid Y, eds. Progressive supranu-clear palsy: clinical and research approaches. New York: Oxford University Press, 1992:254-269.
88. Villares J, Strada O, Faucheux B, et al. Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease. Neurosci Lett 1994; 182:59-62.
89. Di Monte DA, Harati Y, Jankovic J, et al. Muscle mitochondrial ATP production in progressive supranuclear palsy. J Neurochem 1994; 62:1631-1634.
90. Tedeschi G, Litvan I, Bonavita S, et al. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain 1997; 120:1541-1552.
91. Davie CA, Barker GJ, Machado C, et al. 1H Magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome [abstract]. Mov Disord 1997;12:270.
92. Spillantini MG, Bird TD, Ghetti B. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol 1998; 8:387-402.